Literature DB >> 14578032

Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence.

SharadaShree R Devarahally1, Richard K Severson, Paul Chuba, Ronald Thomas, Kanta Bhambhani, Merlin R Hamre.   

Abstract

The standardized incidence ratios (SIR) and cumulative incidence rates were determined for developing second malignant neoplasms (SMNs) after primary central nervous system (CNS) malignancies occurring during childhood using registry data. A total of 4553 cases of primary CNS malignancies were identified. Forty-six cases developed SMNs, 19 occurring in a previously radiated field. The SIRs of developing second malignant neoplasms were 6.3 and 3.1 for those cases receiving and not receiving radiation therapy, respectively. The 20-year cumulative incidences for developing SMNs were 3.3 and 1.2% for cases receiving and not receiving radiation therapy, respectively. Children surviving CNS malignancies have an increased susceptibility for SMNs.

Entities:  

Mesh:

Year:  2003        PMID: 14578032

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  10 in total

1.  Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation.

Authors:  Phillip J Taddei; Anita Mahajan; Dragan Mirkovic; Rui Zhang; Annelise Giebeler; David Kornguth; Mark Harvey; Shiao Woo; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Treatment-related secondary cancer in malignant meningiomas: a population-based study.

Authors:  Xuhui Bao; Lanfang Cao; Hailan Piao; Liyi Xie
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-08       Impact factor: 4.553

3.  Hodgkin's lymphoma in an adolescent previously treated with surgical resection of third ventricular juvenile pilocytic astrocytoma.

Authors:  Dillon Y Chen; John Ross Crawford
Journal:  BMJ Case Rep       Date:  2015-06-25

4.  Risk of subsequent cancer following a primary CNS tumor.

Authors:  Kyle Strodtbeck; Andrew Sloan; Lisa Rogers; Paul Graham Fisher; Duncan Stearns; Laura Campbell; Jill Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2013-02-08       Impact factor: 4.130

Review 5.  An integrative view on sex differences in brain tumors.

Authors:  Tao Sun; Anya Plutynski; Stacey Ward; Joshua B Rubin
Journal:  Cell Mol Life Sci       Date:  2015-05-19       Impact factor: 9.261

6.  Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.

Authors:  Kyung-Nam Koh; Keon Hee Yoo; Ho Joon Im; Ki Woong Sung; Hong Hoe Koo; Hyo Sun Kim; Jung Woo Han; Jong Hyung Yoon; Hyeon Jin Park; Byung-Kiu Park; Hee Jo Baek; Hoon Kook; Jun Ah Lee; Jae Min Lee; Kwang Chul Lee; Soon Ki Kim; Meerim Park; Young-Ho Lee; Chuhl Joo Lyu; Jong Jin Seo
Journal:  J Korean Med Sci       Date:  2016-05-18       Impact factor: 2.153

Review 7.  Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer.

Authors:  Jeronay King Thomas; Hina Mir; Neeraj Kapur; Shailesh Singh
Journal:  Cancers (Basel)       Date:  2019-11-25       Impact factor: 6.639

8.  Systemic cancer therapy: achievements and challenges that lie ahead.

Authors:  Michael O Palumbo; Petr Kavan; Wilson H Miller; Lawrence Panasci; Sarit Assouline; Nathalie Johnson; Victor Cohen; Francois Patenaude; Michael Pollak; R Thomas Jagoe; Gerald Batist
Journal:  Front Pharmacol       Date:  2013-05-07       Impact factor: 5.810

9.  Gender differences in cancer susceptibility: an inadequately addressed issue.

Authors:  M Tevfik Dorak; Ebru Karpuzoglu
Journal:  Front Genet       Date:  2012-11-28       Impact factor: 4.599

10.  Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study.

Authors:  Gregory T Armstrong; Qi Liu; Yutaka Yasui; Sujuan Huang; Kirsten K Ness; Wendy Leisenring; Melissa M Hudson; Sarah S Donaldson; Allison A King; Marilyn Stovall; Kevin R Krull; Leslie L Robison; Roger J Packer
Journal:  J Natl Cancer Inst       Date:  2009-06-17       Impact factor: 11.816

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.